Sphingomyelin Synthase 2 Is One of the Determinants for Plasma and Liver Sphingomyelin Levels in Mice

Department of Anatomy and Cell Biology, State University of New York Downstate Medical Center, 450 Clarkson Ave, Box 5, Brooklyn, NY 11203, USA.
Arteriosclerosis Thrombosis and Vascular Biology (Impact Factor: 5.53). 04/2009; 29(6):850-6. DOI: 10.1161/ATVBAHA.109.185223
Source: PubMed

ABSTRACT It has been proposed that plasma sphingomyelin (SM) plays a very important role in plasma lipoprotein metabolism and atherosclerosis. Sphingomyelin synthase (SMS) is the last enzyme for SM de novo biosynthesis. Two SMS genes, SMS1 and SMS2, have been cloned and characterized.
To evaluate the in vivo role of SMS2 in SM metabolism, we prepared SMS2 knockout (KO) and SMS2 liver-specific transgenic (LTg) mice and studied their plasma SM and lipoprotein metabolism. On a chow diet, SMS2 KO mice showed a significant decrease in plasma SM levels (25%, P<0.05), but no significant changes in total cholesterol, total phospholipids, or triglyceride, compared with wild-type (WT) littermates. On a high-fat diet, SMS2 KO mice showed a decrease in plasma SM levels (28%, P<0.01), whereas SMS2LTg mice showed a significant increase in those levels (29%, P<0.05), but no significant changes in other lipids, compared with WT littermates. Atherogenic lipoproteins from SMS2LTg mice displayed a significantly stronger tendency toward aggregation after mammalian sphingomyelinase treatment, compared with controls. Moreover, SMS2 deficiency significantly increased plasma apoE levels (2.0-fold, P<0.001), whereas liver-specific SMS2 overexpression significantly decreased those levels (1.8-fold, P<0.01). Finally, SMS2 KO mouse plasma promoted cholesterol efflux from macrophages, whereas SMS2LTg mouse plasma prevented it.
We therefore believe that regulation of liver SMS2 activity could become a promising treatment for atherosclerosis.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sphingomyelin synthase (SMS) is a key enzyme for the synthesis of mammalian sphingomyelin. SMS plays diverse roles in physiology and pathology, thus, it could be a useful disease marker and/or drug target. We report here a novel and sensitive method for SMS activity measurement. Using a HPLC column (C18-RP), SMS activity was monitored by measuring a decrease of the fluorescent substrate C6-4-nitrobenzo-2-oxa-1,3-diazole (NBD)-ceramide (C6-NBD-Cer) and increase of the product (C6-NBD-SM). Time- and protein-dependent formation of C6-NBD-SM was investigated and enzyme kinetics was determined [Km = 7.49 ± 0.48 µM (C6-NBD-Cer) and Vmax = 27.86 ± 0.73fmol/h/mg homogenate protein]. This method is feasible, rapid, accurate, and highly reproducible, and suitable for quantifying SMS enzyme activity in SMS inhibitor screening studies. A known SMS inhibitor, D609, was employed to evaluate the assay and its IC50 value has been determined.
    Analytical Letters 08/2012; DOI:10.1080/00032719.2012.677780 · 0.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The plasma membrane (PM) is a major resource for production of bioactive lipids and contains a large proportion of the cellular sphingomyelin (SM) content. Consequently, the regulation of SM levels at the PM by enzymes such as sphingomyelinase (SMase) and SM synthase 2 (SMS2) can have profound effects - both on biophysical properties of the membrane, but also on cellular signaling. Over the past 20 years, there has been considerable research into the physiological and cellular functions associated with regulation of SM levels, notably with regards to the production of ceramide. In this review, we will summarize this research with particular focus on the SMases and SMS2. We will outline what biological functions are associated with SM metabolism/production at the PM, and discuss what we believe are major challenges that need to be addressed in future studies.
    FEBS letters 10/2009; 584(9):1887-94. DOI:10.1016/j.febslet.2009.10.058 · 3.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The effect of coffee consumption on human health is still discussed controversially. Here, we report results from a metabolomics study of coffee consumption, where we measured 363 metabolites in blood serum of 284 male participants of the Cooperative Health Research in the Region of Augsburg study population, aged between 55 and 79 years. A statistical analysis of the association of metabolite concentrations and the number of cups of coffee consumed per day showed that coffee intake is positively associated with two classes of sphingomyelins, one containing a hydroxy-group (SM(OH)) and the other having an additional carboxy-group (SM(OH,COOH)). In contrast, long- and medium-chain acylcarnitines were found to decrease with increasing coffee consumption. It is noteworthy that the concentration of total cholesterol also rises with an increased coffee intake in this study group. The association observed here between these hydroxylated and carboxylated sphingolipid species and coffee intake may be induced by changes in the cholesterol levels. Alternatively, these molecules may act as scavengers of oxidative species, which decrease with higher coffee intake. In summary, we demonstrate strong positive associations between coffee consumption and two classes of sphingomyelins and a negative association between coffee consumption and long- and medium-chain acylcarnitines.
    Molecular Nutrition & Food Research 11/2009; 53(11):1357-65. DOI:10.1002/mnfr.200900116 · 4.91 Impact Factor


1 Download
Available from